These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38180458)

  • 1. Central Sleep Apnea in Patients With Coronary Heart Disease Taking P2Y12 Inhibitors.
    Tzeng WS; Klein CF; Roth RH; Cho Y; Munagala R; Bonner H; Mazimba S; Khayat R; Healy W; Lobo JM; Kapur VK; Kwon Y
    J Cardiovasc Pharmacol; 2024 Jan; 83(1):126-130. PubMed ID: 38180458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ticagrelor-Associated Shift From Obstructive to Central Sleep Apnea: A Case Report.
    Paboeuf C; Priou P; Meslier N; Roulaud F; Trzepizur W; Gagnadoux F
    J Clin Sleep Med; 2019 Aug; 15(8):1179-1182. PubMed ID: 31482841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central sleep apnea after acute coronary syndrome and association with ticagrelor use.
    Meurin P; Ben Driss A; Defrance C; Dumaine R; Weber H; Renaud N; Bonnevie L; Mouram S; Tabet JY
    Sleep Med; 2021 Apr; 80():39-45. PubMed ID: 33550173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends for and Clinical Factors Associated with Choice of Oral P2Y
    Jain N; Hunt SL; Cui H; Phadnis MA; Mahnken JD; Shireman TI; Dai J; Mehta JL; Rasu RS
    Cardiovasc Drugs Ther; 2019 Oct; 33(5):511-521. PubMed ID: 31729588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe central sleep apnea is associated with atrial fibrillation in patients with left ventricular systolic dysfunction.
    Grimm W; Sass J; Sibai E; Cassel W; Hildebrandt O; Apelt S; Nell C; Koehler U
    Pacing Clin Electrophysiol; 2015 Jun; 38(6):706-12. PubMed ID: 25196395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Ticagrelor vs Clopidogrel With Major Adverse Coronary Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    Turgeon RD; Koshman SL; Youngson E; Har B; Wilton SB; James MT; Graham MM
    JAMA Intern Med; 2020 Mar; 180(3):420-428. PubMed ID: 31930361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the Clinical Treatment Dynamics of Antiplatelet Therapy Following Acute Coronary Syndrome and Percutaneous Coronary Intervention in the US.
    Wang Y; Cavallari LH; Brown JD; Thomas CD; Winterstein AG
    JAMA Netw Open; 2023 Apr; 6(4):e238585. PubMed ID: 37067798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Ticagrelor vs Clopidogrel With Net Adverse Clinical Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    You SC; Rho Y; Bikdeli B; Kim J; Siapos A; Weaver J; Londhe A; Cho J; Park J; Schuemie M; Suchard MA; Madigan D; Hripcsak G; Gupta A; Reich CG; Ryan PB; Park RW; Krumholz HM
    JAMA; 2020 Oct; 324(16):1640-1650. PubMed ID: 33107944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and risk factors for central sleep apnea in infants with laryngomalacia.
    Tanphaichitr A; Tanphaichitr P; Apiwattanasawee P; Brockbank J; Rutter MJ; Simakajornboon N
    Otolaryngol Head Neck Surg; 2014 Apr; 150(4):677-83. PubMed ID: 24493785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central sleep apnea in left ventricular dysfunction: prevalence and implications for arrhythmic risk.
    Lanfranchi PA; Somers VK; Braghiroli A; Corra U; Eleuteri E; Giannuzzi P
    Circulation; 2003 Feb; 107(5):727-32. PubMed ID: 12578876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Coronary Heart Disease Risk in Hemodialysis Patients with Central Sleep Apnea: A Pilot Study.
    Sakura M; Inaba M; Yoda K; Ichii M; Yamada S; Yamakawa T; Ishimura E; Okuno S; Shoji S
    Am J Nephrol; 2016; 44(5):388-395. PubMed ID: 27771703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in Treatment Patterns and Incremental Health Care Utilization Due to P2Y12-Associated Complications in Patients with Acute Coronary Syndrome.
    Vyas A; Bash LD; Patel MD; Simpson RJ
    J Manag Care Spec Pharm; 2017 Sep; 23(9):947-956. PubMed ID: 28854078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic opioid use and central sleep apnea: a review of the prevalence, mechanisms, and perioperative considerations.
    Correa D; Farney RJ; Chung F; Prasad A; Lam D; Wong J
    Anesth Analg; 2015 Jun; 120(6):1273-85. PubMed ID: 25988636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-year efficacy and safety of prasugrel and ticagrelor in patients with acute coronary syndromes: Results from a prospective and multicentre ACHILLES registry.
    Ruiz-Nodar JM; Esteve-Pastor MA; Rivera-Caravaca JM; Sandín M; Lozano T; Vicente-Ibarra N; Orenes-Piñero E; Macías MJ; Pernías V; Carrillo L; Candela E; Veliz A; Tello-Montoliu A; Martínez Martínez JG; Marín F
    Br J Clin Pharmacol; 2020 Jun; 86(6):1052-1061. PubMed ID: 31912949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet Inhibition with Ticagrelor versus Clopidogrel in Diabetic Patients after Percutaneous Coronary Intervention for Chronic Coronary Syndromes.
    Liu Z; Tian R; Wang Y; Chen Q; Li J; Xu L; Zhang S
    Thromb Haemost; 2020 Aug; 120(8):1221-1229. PubMed ID: 32668483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Ticagrelor Versus Clopidogrel on Bleeding Outcomes of Isolated Coronary Artery Bypass Grafting.
    Ingrassia JJ; Mosleh W; Conner CM; Mather JF; Loya DS; Yaffee DW; Sutton TS; Takata ET; McMahon SR; Hashim SW; McKay RG
    Cardiovasc Revasc Med; 2023 Jan; 46():44-51. PubMed ID: 35961855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention: The TAILOR-PCI Randomized Clinical Trial.
    Pereira NL; Farkouh ME; So D; Lennon R; Geller N; Mathew V; Bell M; Bae JH; Jeong MH; Chavez I; Gordon P; Abbott JD; Cagin C; Baudhuin L; Fu YP; Goodman SG; Hasan A; Iturriaga E; Lerman A; Sidhu M; Tanguay JF; Wang L; Weinshilboum R; Welsh R; Rosenberg Y; Bailey K; Rihal C
    JAMA; 2020 Aug; 324(8):761-771. PubMed ID: 32840598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of central sleep apnea to severe sleep apnea hypopnea syndrome.
    Zhang G; Zhao X; Zhao F; Tan J; Zhang Q
    Sleep Breath; 2023 Oct; 27(5):1839-1845. PubMed ID: 36849673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial.
    Oldgren J; Steg PG; Hohnloser SH; Lip GYH; Kimura T; Nordaby M; Brueckmann M; Kleine E; Ten Berg JM; Bhatt DL; Cannon CP
    Eur Heart J; 2019 May; 40(19):1553-1562. PubMed ID: 30793734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials.
    Galli M; Benenati S; Franchi F; Rollini F; Capodanno D; Biondi-Zoccai G; Vescovo GM; Cavallari LH; Bikdeli B; Ten Berg J; Mehran R; Gibson CM; Crea F; Pereira NL; Sibbing D; Angiolillo DJ
    Eur Heart J; 2022 Mar; 43(10):959-967. PubMed ID: 34918066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.